Quality of Life in the Chronic GVHD Consortium Cohort: Lessons Learned and the Long Road Ahead Christa KrupskiMadan Jagasia Health Economics (N Khera, Section Editor) 25 August 2015 Pages: 183 - 191
Persistent Disparities in Adult Hematopoietic Cell Transplantation David G. CrockettFausto R. Loberiza Jr Health Economics (N Khera, Section Editor) 24 June 2015 Pages: 192 - 198
Optimizing Quality and Efficiency of Healthcare Delivery in Hematopoietic Cell Transplantation Navneet S Majhail Health Economics (N Khera, Section Editor) 24 May 2015 Pages: 199 - 204
Financial Hardship—an Unwanted Consequence of Cancer Treatment Julie McNultyNandita Khera Health Economics (N Khera, Section Editor) 26 June 2015 Pages: 205 - 212
The Value of Patient Reported Outcomes and Other Patient-Generated Health Data in Clinical Hematology Hemant S. MurthyWilliam A. Wood Health Economics (N Khera, Section Editor) 04 June 2015 Pages: 213 - 224
A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies Marlise R. LuskinRahul BanerjeeAlison W. Loren Health Economics (N Khera, Section Editor) 11 July 2015 Pages: 225 - 236
Non-Hodgkin Lymphoma in Children John T. Sandlund B-cell NHL, T-cell NHL and Hodgkin Lymphoma (J Armitage, Section Editor) 15 July 2015 Pages: 237 - 243
To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes Jean L. KoffDai ChiharaChristopher R. Flowers B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Armitage, Section Editor) 24 June 2015 Pages: 244 - 255
The GHSG Approach to Treating Hodgkin’s Lymphoma Paul J. BröckelmannAndreas Engert B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Armitage, Section Editor) 30 May 2015 Pages: 256 - 265
Treating Burkitt Lymphoma in Adults Carla CasuloJonathan Friedberg B-cell NHL, T-cell NHL, and Hodgkin Lymphoma (J Armitage, Section Editor) 27 May 2015 Pages: 266 - 271
Incidence and Burden of the Myelodysplastic Syndromes Christopher R. Cogle Myelodysplastic Syndromes (D Steensma, Section Editor) Open access 02 July 2015 Pages: 272 - 281
Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing? Rafael Bejar Myelodysplastic Syndromes (D Steensma, Section Editor) Open access 01 July 2015 Pages: 282 - 291
Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update Kristen B. McCulloughMrinal M. Patnaik Myelodysplastic Syndromes (D Steensma, Section Editor) 28 June 2015 Pages: 292 - 302
Where Does Lenalidomide Fit in Non-del(5q) MDS? Aristoteles Giagounidis Myelodysplastic Syndromes (D Steensma, Section Editor) 14 July 2015 Pages: 303 - 308
Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes? Anna Porwit Myelodysplastic Syndromes (D Steensma, Section Editor) 01 July 2015 Pages: 309 - 317
Outlook and Management of Patients with Myelodysplastic Syndromes Failed by Hypomethylating Agents Daniel A. RobertsDavid P. Steensma Myelodysplastic Syndromes (D Steensma, Section Editor) 01 July 2015 Pages: 318 - 328
Preparing Patients With Myelodysplastic Syndrome for Transplant When Is Pre-transplant Cytoreductive Therapy Appropriate? Martin WermkeSilke GloaguenUwe Platzbecker Myelodysplastic Syndromes (D Steensma, Section Editor) 01 July 2015 Pages: 329 - 333
